Home › Colitis ulcerosa › Illinois › Chicago
Colitis ulcerosa klinische studies in Chicago, IL
15 studies voor Colitis ulcerosa zoeken deelnemers op locaties in en rond Chicago (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
RekruterenFase 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
RekruterenFase 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
RekruterenFase 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
RekruterenFase 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RekruterenFase 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RekruterenFase 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
RekruterenFase 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
RekruterenFase 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
RekruterenFase 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
RekruterenFase 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Rekruteren
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
RekruterenObservatieonderzoek
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
RekruterenFase 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
RekruterenFase 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Rekruteren
- University of Chicago, Chicago
Colitis ulcerosa studies in andere steden
- New York City, NY23 studies
- Orlando, FL22 studies
- Miami, FL21 studies
- Houston, TX17 studies
- San Antonio, TX16 studies
- Tacoma, WA15 studies
- San Diego, CA15 studies
- Tyler, TX14 studies
- Colorado Springs, CO14 studies
- Los Angeles, CA13 studies
- St. Louis, MO13 studies
- Washington, DC12 studies
Andere studies in Chicago
- Niet-kleincellige longkanker61 studies
- Borstkanker58 studies
- Kanker (alle vormen)51 studies
- Metastatische kanker45 studies
- Prostaatkanker45 studies
- Obesitas41 studies
- Longkanker41 studies
- Eierstokkanker36 studies
- Beroerte34 studies
- Colorectale kanker33 studies
- Hartfalen31 studies
- Overgewicht28 studies
Van ClinicalTrials.gov, gegevens opgehaald op 3 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.